- Home
- A-Z Publications
- Letters in Drug Design & Discovery
- Previous Issues
- Volume 1, Issue 2, 2004
Letters in Drug Design & Discovery - Volume 1, Issue 2, 2004
Volume 1, Issue 2, 2004
-
-
Molecular Modulation of Muscarinic Antagonists. Synthesis and Pharmacological Profile of 2,2-diphenyl-2-ethylthioacetic and 3,3-diphenyl-3- ethylthiopropionic Acid Derivatives Characterized by a Dipeptide Spacer
Authors: S. Scapecchi, C. Martelli, P. Angeli, C. Bellucci, M. Buccioni, S. Dei, F. Gualtieri, G. Marucci, R. Matucci and M. N. RomanelliThe synthesis and preliminary pharmacological profile of a new series of muscarinic antagonists are reported. Discrepancies between binding and functional studies have been found as the compounds of the series do not discriminate among muscarinic subtypes but do show functional selectivity in tissue assays. The most interesting compound 7 shows a good potency and selectivity for the muscarinic M3 receptors pres Read More
-
-
-
Quaternary Heteroarenium Salts as the Competitive Inhibitors of the Brain Acetylcholinesterase
Authors: Kamil Kuca, Jiri Cabal, Jiri Patocka and Vlastimil DohnalThe interaction of seventeen heteroarenium salts with the enzyme acetylcholinesterase was investigated using in vitro experiments. Rat brains were used as a source of the enzyme. All compounds involved in this study were found to be competitive acetylcholinesterase inhibitors. 10-methyl-acridinium iodide seems to be the most potent acetylcholinesterase inhibitor.
-
-
-
Distinct Dimerization Between α-Lactalbumin and Lysozyme Exhibiting Novel Antimicrobial Activity against Gram-positive and Gram-negative Bacteria
Authors: Hisham R. Ibrahim, Norihiko Taniyama and Takayoshi AokiAlpha-lactalbumin (α-LA) and c-type lysozyme (cLZ) are two proteins structurally similar but largely different in their biochemical properties. Despite c-type lysozyme is widely distributed in nature from bacteria to human, α-lactalbumin is the only of mammalian products. These two proteins uniquely co-exist in mammalian milk but the significance of their distinct presence in milk is completely unknown. In this study, hen egg Read More
-
-
-
Challenges of Anthrax Drug Design: In Search of “Achilles' heel” of Bacillus anthracis
More LessBacillus anthracis, the etiologic agent of anthrax, is perceived as a potential biological warfare agent. In this review, recent advances made on infection process of B. anthracis are summarized and treatment strategies are discussed.
-
-
-
Comparative Study of 3D-QSAR Techniques on Angiotensin II Receptor (AT1) Antagonists
Authors: P. A. Datar, E. C. Coutinho and Sudha SrivastavaThree different 3D-QSAR methods namely CoMFA, CoMSIA and RSA were applied to a set of 38 angiotensin type 1 receptor (AT1) antagonists. The conformation and alignment of molecules used in each of the three QSAR methods were obtained by a novel method - Consensus Dynamics. To derive the best CoMFA model, various parameters such as partial charge formalism, grid spacing and the absolute orientation of the mo Read More
-
-
-
Diverse Peptidyl Privileged Structures as Potent Somatostatin Receptor Ligands
This report describes the evaluation of a wide range of structurally diverse “privileged structures”, either amines or acids, linked via urea and amide connections, to the key dipeptide D-Trp-Lys-OMe. This led to the discovery of a collection of potent and structurally distinct SSTR2 ligands in both the amide and urea series. The 4- (benzimidazolone)-piperidine linked SSTR2 agonist (8) is highlighted.
-
-
-
Rational Design of Chemokine SDF-1 Analogs with Agonist Activity for the CXCR4 Receptor and the Capacity to Rapidly Mobilize PMN and Hematopoietic Progenitor Cells in Mice
Authors: Ahmed Merzouk, Donald Wong, Hassan Salari, Huimin Bian, Seiji Fukuda and Louis M. PelusWe designed SDF-1α / CXCL12 (1) analogs to improve in vivo bioactivity. A linear analogue (2) consisting of AA1-14 of (1) joined by (Gly)4 to AA56-67 binds CXCR4, but with ∼100-fold less affinity. Cyclized analogs (3) and (4) were 2-3-fold more active. Substitution of the cysteines in analog (3) forming analog (5) prevented dimerization and increased plasma stability. Analogs (3) and (5) rapidly mobilized neutrophils and hematop Read More
-
-
-
Thalidomide as an Antiangiogenic Drug in the Treatment of Multiple Myeloma
Authors: Domenico Ribatti and Angelo VaccaExperimental studies have demonstrated that thalidomide, a drug developed as a sedative, has antitumoral properties. Its broad spectrum of actions besides its antiangiogenic potential, includes immunomodulatory properties, antiinflammatory actions and direct effect on tumor cells and their microenvironment. Multiple myeloma is so far the most responsive malignancy.
-
-
-
Recombinant Murine Polyoma Virus-like-particles Induce Protective Antitumour Immunity
Authors: M. Brinkman, J. Walter, I. Jennes, M. Neugebauer, W. Bertling, S. Grein, M. Thies, M. Weigand, T. Beyer and M. HerrmannSubcutaneous vaccination of mice with chimerical polyomavirus-likeparticles consisting of a VP1-ovalbumin (OVA252-270) fusion protein induced immunodominant H-2Kb-restricted and OVA257-264-specific CD8 T cells in mice. Single immunisations with VP1-OVA252-270 capsoids failed to have beneficial effects on tumour protection, only double vaccinations in weekly intervals protected mice from lethal MO5 melanoma challenge.
-
-
-
Catecholamines, Sympathetic Innervation and Immunity: Role in Experimental and Rheumatoid Arthritis
More LessThe sympathetic nervous system (SNS) has a major role in homeostatic control of inflammatory and antigen specific immune reactions. This review summarizes the evidence that the SNS can enhance or suppress immune function, that SNS dysregulation is a critical component of the immune system dysregulation that underlies rheumatoid arthritis (RA) pathology and that the SNS may be targeted in RA to restore immune syst Read More
-
-
-
Steps towards Phage Display Libraries with an Extended Amino Acid Repertoire
Authors: M. Bjorklund and E. KoivunenTo increase the peptide diversity of phage display libraries, we examined the incorporation of amino acid analogues into bacteriophage using auxotrophic E. coli strains. Fluorinated tryptophan analogues and norleucine were efficiently incorporated into phage particles. Phage display of unnatural amino acids may have wide applications in the drug discovery process.
-
-
-
Urocortin: Cardiovascular Actions and Therapeutic Implications
More LessUrocortin, expressed throughout the heart and vasculature, has potent effects on the cardiovascular system including vasodilation, increases in cardiac contractility and coronary blood flow, and protection of the myocardium against ischemia / reperfusion damage. This range of actions suggests urocortin has therapeutic potential in states of cardiac dysfunction and injury.
-
-
-
Towards an Experimental de Novo Design Protocol. The use of Protein Crystallography to Deconvolute Dynamic Combinatorial Processes
Authors: Robert E. Babine, Michael J. Rynkiewicz, Lei Jin and Sherin S. Abdel-MeguidPreliminary experiments demonstrate that the results of dynamic combinatorial chemistry (DCC) processes can be deconvoluted using X-ray crystallography. The examples reported involve adduct formation between serine proteases, boric acid and a mixture of as many as eleven alcohols. Several DCC experiments are described and in each case X-ray crystallography provides a useful tool for product identification. Read More
-
-
-
Grid-Based Hydrogen Bond Potentials with Improved Directionality
Authors: Ruth Huey, David S. Goodsell, Garrett M. Morris and Arthur J. OlsonGrid-based methods are widely used for evaluation of conformations in automated docking and other techniques of structure-based drug design. Traditional non-directional and directional methods for evaluating hydrogen bonds in these methods, however, yield improper interactions in cases with adjacent hydrogen bonds, such as those that mediate base pairing in nucleic acids. An improved method of calculating hydrogen b Read More
-
Volumes & issues
-
Volume 21 (2024)
-
Volume 20 (2023)
-
Volume 19 (2022)
-
Volume 18 (2021)
-
Volume 17 (2020)
-
Volume 16 (2019)
-
Volume 15 (2018)
-
Volume 14 (2017)
-
Volume 13 (2016)
-
Volume 12 (2015)
-
Volume 11 (2014)
-
Volume 10 (2013)
-
Volume 9 (2012)
-
Volume 8 (2011)
-
Volume 7 (2010)
-
Volume 6 (2009)
-
Volume 5 (2008)
-
Volume 4 (2007)
-
Volume 3 (2006)
-
Volume 2 (2005)
-
Volume 1 (2004)
Most Read This Month
Article
content/journals/lddd
Journal
10
5
false
en
